Aysegul Ozen

Follow

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
EGFR inhibitors
- Patent number 11,718,602
- Issue date Aug 8, 2023
- Blueprint Medicines Corporation
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER
- Publication number 20240382483
- Publication date Nov 21, 2024
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER
- Publication number 20240308981
- Publication date Sep 19, 2024
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER
- Publication number 20240299387
- Publication date Sep 12, 2024
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EGFR INHIBITORS
- Publication number 20230056541
- Publication date Feb 23, 2023
- BLUEPRINT MEDICINES CORPORATION
- John Emmerson Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EGFR INHIBITORS
- Publication number 20230026209
- Publication date Jan 26, 2023
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY